Antiretroviral therapy and HIV prevention in India: Modeling costs and consequences of policy options

Mead Over, Elliot Marseille, Kurapati Sudhakar, Julian Gold, Indrani Gupta, Abhaya Indrayan, Subhash Hira, Nico Nagelkerke, Arni S R Rao, Peter Heywood

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVES: The objective of this study is to assess the costs, cost-effectiveness, and HIV epidemic impact of 3 antiretroviral therapy (ART) policy options. STUDY DESIGN: We constructed an epidemiologic model to predict the course of the HIV epidemic in the absence of expanded ART availability. Based on background studies of the willingness to pay for ART among patients with AIDS, of the costs to the government of the alternative treatment interventions, and of ART's likely effects on HIV transmission, we simulated the consequences of 3 possible alternative government ART policies. RESULTS: A program to reduce the negative consequences of the currently unstructured private-sector provision of ART is the most cost-effective of the 3 options at a 10% discount rate and least cost-effective at a 3% rate. The costs and cost-effectiveness of all options are highly sensitive to the effect of ART on condom use. CONCLUSION: The design of ART policy should capitalize on the potential of ART to decrease HIV transmission through institutional arrangements that reward effective prevention programs, thereby raising the likelihood that treatment has beneficial rather than negative external effects.

Original languageEnglish (US)
JournalSexually Transmitted Diseases
Volume33
Issue number10 SUPPL.
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

Fingerprint

India
HIV
Costs and Cost Analysis
Therapeutics
Cost-Benefit Analysis
Private Sector
Condoms
Reward
Acquired Immunodeficiency Syndrome

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Antiretroviral therapy and HIV prevention in India : Modeling costs and consequences of policy options. / Over, Mead; Marseille, Elliot; Sudhakar, Kurapati; Gold, Julian; Gupta, Indrani; Indrayan, Abhaya; Hira, Subhash; Nagelkerke, Nico; Rao, Arni S R; Heywood, Peter.

In: Sexually Transmitted Diseases, Vol. 33, No. 10 SUPPL., 01.10.2006.

Research output: Contribution to journalArticle

Over, M, Marseille, E, Sudhakar, K, Gold, J, Gupta, I, Indrayan, A, Hira, S, Nagelkerke, N, Rao, ASR & Heywood, P 2006, 'Antiretroviral therapy and HIV prevention in India: Modeling costs and consequences of policy options', Sexually Transmitted Diseases, vol. 33, no. 10 SUPPL.. https://doi.org/10.1097/01.olq.0000238457.93426.0d
Over, Mead ; Marseille, Elliot ; Sudhakar, Kurapati ; Gold, Julian ; Gupta, Indrani ; Indrayan, Abhaya ; Hira, Subhash ; Nagelkerke, Nico ; Rao, Arni S R ; Heywood, Peter. / Antiretroviral therapy and HIV prevention in India : Modeling costs and consequences of policy options. In: Sexually Transmitted Diseases. 2006 ; Vol. 33, No. 10 SUPPL.
@article{b9e6b744486f410ba014cffe946a5e82,
title = "Antiretroviral therapy and HIV prevention in India: Modeling costs and consequences of policy options",
abstract = "OBJECTIVES: The objective of this study is to assess the costs, cost-effectiveness, and HIV epidemic impact of 3 antiretroviral therapy (ART) policy options. STUDY DESIGN: We constructed an epidemiologic model to predict the course of the HIV epidemic in the absence of expanded ART availability. Based on background studies of the willingness to pay for ART among patients with AIDS, of the costs to the government of the alternative treatment interventions, and of ART's likely effects on HIV transmission, we simulated the consequences of 3 possible alternative government ART policies. RESULTS: A program to reduce the negative consequences of the currently unstructured private-sector provision of ART is the most cost-effective of the 3 options at a 10{\%} discount rate and least cost-effective at a 3{\%} rate. The costs and cost-effectiveness of all options are highly sensitive to the effect of ART on condom use. CONCLUSION: The design of ART policy should capitalize on the potential of ART to decrease HIV transmission through institutional arrangements that reward effective prevention programs, thereby raising the likelihood that treatment has beneficial rather than negative external effects.",
author = "Mead Over and Elliot Marseille and Kurapati Sudhakar and Julian Gold and Indrani Gupta and Abhaya Indrayan and Subhash Hira and Nico Nagelkerke and Rao, {Arni S R} and Peter Heywood",
year = "2006",
month = "10",
day = "1",
doi = "10.1097/01.olq.0000238457.93426.0d",
language = "English (US)",
volume = "33",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Antiretroviral therapy and HIV prevention in India

T2 - Modeling costs and consequences of policy options

AU - Over, Mead

AU - Marseille, Elliot

AU - Sudhakar, Kurapati

AU - Gold, Julian

AU - Gupta, Indrani

AU - Indrayan, Abhaya

AU - Hira, Subhash

AU - Nagelkerke, Nico

AU - Rao, Arni S R

AU - Heywood, Peter

PY - 2006/10/1

Y1 - 2006/10/1

N2 - OBJECTIVES: The objective of this study is to assess the costs, cost-effectiveness, and HIV epidemic impact of 3 antiretroviral therapy (ART) policy options. STUDY DESIGN: We constructed an epidemiologic model to predict the course of the HIV epidemic in the absence of expanded ART availability. Based on background studies of the willingness to pay for ART among patients with AIDS, of the costs to the government of the alternative treatment interventions, and of ART's likely effects on HIV transmission, we simulated the consequences of 3 possible alternative government ART policies. RESULTS: A program to reduce the negative consequences of the currently unstructured private-sector provision of ART is the most cost-effective of the 3 options at a 10% discount rate and least cost-effective at a 3% rate. The costs and cost-effectiveness of all options are highly sensitive to the effect of ART on condom use. CONCLUSION: The design of ART policy should capitalize on the potential of ART to decrease HIV transmission through institutional arrangements that reward effective prevention programs, thereby raising the likelihood that treatment has beneficial rather than negative external effects.

AB - OBJECTIVES: The objective of this study is to assess the costs, cost-effectiveness, and HIV epidemic impact of 3 antiretroviral therapy (ART) policy options. STUDY DESIGN: We constructed an epidemiologic model to predict the course of the HIV epidemic in the absence of expanded ART availability. Based on background studies of the willingness to pay for ART among patients with AIDS, of the costs to the government of the alternative treatment interventions, and of ART's likely effects on HIV transmission, we simulated the consequences of 3 possible alternative government ART policies. RESULTS: A program to reduce the negative consequences of the currently unstructured private-sector provision of ART is the most cost-effective of the 3 options at a 10% discount rate and least cost-effective at a 3% rate. The costs and cost-effectiveness of all options are highly sensitive to the effect of ART on condom use. CONCLUSION: The design of ART policy should capitalize on the potential of ART to decrease HIV transmission through institutional arrangements that reward effective prevention programs, thereby raising the likelihood that treatment has beneficial rather than negative external effects.

UR - http://www.scopus.com/inward/record.url?scp=33749017038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749017038&partnerID=8YFLogxK

U2 - 10.1097/01.olq.0000238457.93426.0d

DO - 10.1097/01.olq.0000238457.93426.0d

M3 - Article

C2 - 17003679

AN - SCOPUS:33749017038

VL - 33

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 10 SUPPL.

ER -